(Q57378877)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619624%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

26 October 2020

An overview on dry eye treatment: approaches for cyclosporin a delivery (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619624%20AND%20SRC:MED&resulttype=core&format=json

keratoconjunctivitis sicca

2 February 2020

main subject

1 reference

26 October 2020

1 reference

20 November 2019

immunosuppressive drug

1 reference

26 October 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619624%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

3

Nurşen Unlü

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619624%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Sibel Bozdağ Pehlivan

series ordinal

2

object named as

Sibel Bozdağ Pehlivan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619624%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

language of work or name

English

0 references

publication date

24 April 2012

6 references

5 March 2019

25 April 2019

13 November 2019

20 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619624%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

26 October 2020

The Scientific World Journal

6 references

5 March 2019

25 April 2019

13 November 2019

20 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619624%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

26 October 2020

2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619624%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

194848

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619624%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution

2 February 2020

copyright license

1 reference

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349326/

copyright status

copyrighted

0 references

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: retrospective analysis of three medical/pharmacy claims databases

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Dry eye: diagnosis and current treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Antiinflammatory therapy for dry eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Advanced delivery of ciclosporin A: present state and perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Ophthalmic delivery of cyclosporine A by punctal plugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Recent developments in dry eye management

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Optic neuropathy in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Botulinum toxin B-induced mouse model of keratoconjunctivitis sicca

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Crystal and molecular structure of an iodo-derivative of the cyclic undecapeptide cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Topical ophthalmic cyclosporine: pharmacology and clinical uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Evaluation of topical cyclosporine for the treatment of dry eye disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Dysfunctional tear syndrome: a Delphi approach to treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

A standardized visual scale for evaluation of tear fluorescein clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

The treatment of dry eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Autologous serum eye drops for ocular surface disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Combination of serum eye drops with hydrogel bandage contact lenses in the treatment of persistent epithelial defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

SmartPlug versus silicone punctal plug therapy for dry eye: a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

The effect of punctal occlusion on tear production, tear clearance, and ocular surface sensation in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

The evolving treatment of dry eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Menopause and tear function: the influence of prolactin and sex hormones on human tear production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Formulation and in-vitro characterization of retinoic acid loaded poly (lactic-co-glycolic acid) microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

The history of cyclosporin A (Sandimmune) revisited: another point of view

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

A comparative approach to topical cyclosporine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Ocular penetration of cyclosporin A. III: The human eye

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Ocular tolerance of preservatives on the murine cornea

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Studies on the transport pathway of PBCA nanoparticles in ocular tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

A new look at dry eye disease and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Value-based medicine, comparative effectiveness, and cost-effectiveness analysis of topical cyclosporine for the treatment of dry eye syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

The mucosal toxicity of different benzalkonium chloride analogues evaluated with an alternative test using slugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Increased corneal hydration induced by potential ocular penetration enhancers: assessment by differential scanning calorimetry (DSC) and by desiccation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Alternative oral exemestane formulation: improved dissolution and permeation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Topical cyclosporine 0.05% for the prevention of dry eye disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Treatment of keratoconjunctivitis sicca in dogs with cyclosporine ophthalmic ointment: a European clinical field trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Cyclosporine A delivery to the eye: A pharmaceutical challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1100%2F2012%2F194848

Management of dry eye disease

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349326

Prevalence, burden, and pharmacoeconomics of dry eye disease.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349326

2 November 2018

Inflammation in dry eye.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349326

Evaluation of retinoic acid ophthalmic emulsion in dry eye.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349326

Ocular rosacea. Signs, symptoms, and tear studies before and after treatment with doxycycline

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349326

Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349326

Bioavailability of microsphere-entrapped cyclosporine A in the cornea and aqueous of rabbits

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349326

Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349326

A comparative rheological study on carbopol viscous solutions and, the evaluation of their suitability as the ophthalmic vehicles and artificial tears

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349326

Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes

2 November 2018

1 reference

12 December 2020

Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjögren's syndrome

1 reference

12 December 2020

The increased efficacy and decreased nephrotoxicity of a cyclosporine liposome

1 reference

12 December 2020

Effect of eyelid botulinum toxin injection on lacrimal drainage

1 reference

12 December 2020

Ocular absorption of cyclosporine A from liposomes incorporated into collagen shields

1 reference

12 December 2020

The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome

1 reference

12 December 2020

The effect on the cornea of alpha cyclodextrin vehicle for cyclosporin eye drops

1 reference

12 December 2020

Improved extemporaneous formulation of cyclosporine ophthalmic drops

1 reference

12 December 2020

Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption

1 reference

12 December 2020

Retinal toxicity study of intravitreal cyclosporin

1 reference

12 December 2020

Topically applied cyclosporine in azone prolongs corneal allograft survival

1 reference

12 December 2020

Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats

1 reference

12 December 2020

Effects of preservative-free artificial tear solutions on corneal epithelial structure and function

1 reference

12 December 2020

Cyclosporin. Formulation of dosage forms

1 reference

12 December 2020

Use of the isolated perfused kidney model to assess the acute pharmacologic effects of cyclosporine and its vehicle, cremophor EL

1 reference

12 December 2020

Classification of artificial tears. II: Additives and commercial formulas

1 reference

12 December 2020

A submicron emulsion as ocular vehicle for delta-8-tetrahydrocannabinol: effect on intraocular pressure in rabbits

1 reference

12 December 2020

Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis

1 reference

12 December 2020

Formulation of Carbopol 940 ophthalmic vehicles, and in vitro evaluation of the influence of simulated lacrimal fluid on their physico-chemical properties

1 reference

12 December 2020

Liposome-bound cyclosporine: aqueous and vitreous level after subconjunctival injection

1 reference

12 December 2020

Polyacrylic acid/polyvinylpyrrolidone bipolymeric systems. I. Rheological and mucoadhesive properties of formulations potentially useful for the treatment of dry-eye-syndrome

1 reference

12 December 2020

Extended cyclosporine delivery by silicone-hydrogel contact lenses

1 reference

12 December 2020

Influence of vehicle and anterior chamber protein concentration on cyclosporine penetration through the isolated rabbit cornea

1 reference

12 December 2020

The collagen shield. A new vehicle for delivery of cyclosporin A to the eye

1 reference

12 December 2020

The pathology of dry eye: the interaction between the ocular surface and lacrimal glands

1 reference

12 December 2020

Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A

1 reference

12 December 2020

Collagen as a delivery system for hydrophobic drugs: studies with cyclosporine

1 reference

12 December 2020

A subconjunctival degradable implant for cyclosporine delivery in corneal transplant therapy

1 reference

12 December 2020

Effect of cyclosporine A formulations on bovine corneal absorption: ex-vivo study

1 reference

12 December 2020

Solvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulations

1 reference

12 December 2020

Safety and Tolerability of Two Percent Cyclosporine (Sandimmune®) Ophthalmic Ointment in Normal Volunteers

1 reference

12 December 2020

Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca

1 reference

12 December 2020

Efficacy of subconjunctival cyclosporin-containing microspheres on keratoplasty rejection in the rabbit

1 reference

12 December 2020

Ketorolac during the induction phase of cyclosporin-A therapy

1 reference

12 December 2020

Diclofenac sodium, 0.1% (Voltaren Ophtha), versus sodium chloride, 5%, in the treatment of filamentary keratitis

1 reference

12 December 2020

Pilocarpine incorporated into a submicron emulsion vehicle causes an unexpectedly prolonged ocular hypotensive effect in rabbits

1 reference

12 December 2020

Cyclosporine A formulation affects its ocular distribution in rabbits

1 reference

12 December 2020

Effects of four penetration enhancers on corneal permeability of drugs in vitro

1 reference

12 December 2020

A pharmacokinetic and safety evaluation of an episcleral cyclosporine implant for potential use in high-risk keratoplasty rejection

1 reference

12 December 2020

Identifiers

DOI

10.1100/2012/194848

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619624%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22619624%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

PubMed publication ID

22619624

1 reference